Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Monoclon Antib Immunodiagn Immunother ; 42(6): 194-202, 2023 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-38156888

RESUMO

Graves' disease is the most common cause of thyrotoxicosis and is characterized by ophthalmopathy with proptosis, chemosis, or conjunctival injection; pretibial myxedema; and thyroid acropachy. It is an autoimmune disease that can be genetic or influenced by coexisting environmental factors such as exposure to anticancer drugs, including immune checkpoint inhibitors. The incidence rate of breast cancer is increasing due to rising awareness of risk factors and screening for breast cancer, and the mortality rate is decreasing due to recent advances in cancer treatment. However, there are side effects that are attributed to these treatment modalities, manifesting in various forms in breast cancer survivors, which are reflected in the patient in this case study.


Assuntos
Neoplasias da Mama , Doença de Graves , Mixedema , Feminino , Humanos , Pessoa de Meia-Idade , Neoplasias da Mama/tratamento farmacológico , Neoplasias da Mama/complicações , Trastuzumab/efeitos adversos , Anticorpos Monoclonais , Doença de Graves/diagnóstico , Doença de Graves/tratamento farmacológico , Doença de Graves/complicações , Mixedema/complicações , Mixedema/terapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...